Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Arena Pharmaceuticals
Arena Pharmaceuticals
Arena's Obesity Drug Not Likely to Make It
Seeking Alpha
Tue, 03/31/09 - 12:55 pm
Arena Pharmaceuticals
obesity
Arena Defends Obesity Drug as Stock Plunges
TheStreet.com
Mon, 03/30/09 - 11:06 am
Arena Pharmaceuticals
obesity
Drug stocks lose ground as broader market sinks
Marketwatch
Mon, 03/30/09 - 11:03 am
drug stocks
Eli Lilly
Merck
JNJ
Arena Pharmaceuticals
Abbott Laboratories
Arena reports positive Phase III results for obesity drug
Marketwatch
Mon, 03/30/09 - 08:31 am
Arena Pharmaceuticals
obesity
Arena's Financing Deal with Azimuth Is a Healthy Move
Seeking Alpha
Wed, 03/25/09 - 07:45 am
Arena Pharmaceuticals
obesity
Azimuth
Obesity Drug Arena's Heavy Burden
TheStreet.com
Mon, 03/23/09 - 09:43 am
obesity
Arena Pharmaceuticals
Vivus
fen phen
Orexigen
Wyeth
lorcaserin
GlaxoSmithKline's New Ally For Alli
CNBC
Fri, 03/20/09 - 11:50 am
GSK
Alli
obesity
Arena Pharmaceuticals
Vivus
Three Ways to Play Arena Pharmaceuticals
Seeking Alpha
Wed, 03/18/09 - 08:35 am
Arena Pharmaceuticals
obesity
Vivus
Contrave
Take Advantage of Market Confusion to Buy Orexigen Therapeutics
Seeking Alpha
Tue, 03/17/09 - 09:26 am
obesity
Orexigen
Contrave
Empatic
Eli Lilly
Arena Pharmaceuticals
Vivus
Arena Pharmaceuticals: Near Term Gamble May Be Worth It
Seeking Alpha
Tue, 03/10/09 - 07:36 am
Arena Pharmaceuticals
obesity
Qnexa
Vivus
Orexigen
Contrave
lorcaserin
Top 10 Biotech Events to Watch
TheStreet.com
Thu, 03/5/09 - 09:16 am
biotech
Genentech
Dendreon
Arena Pharmaceuticals
Biogen Idec
Amylin
Vertex Pharmaceuticals
Vivus: A Bet on Well-Funded, Late-Stage Pipeline 3 comments
Seeking Alpha
Wed, 03/4/09 - 09:19 am
Vivus
pipelines
obesity
Arena Pharmaceuticals
Orexigen
Analyst Actions: Agilent, Arena Pharmaceuticals
Businessweek
Thu, 02/19/09 - 08:34 am
Agilent
Arena Pharmaceuticals
UBS downgrades Arena to 'Neutral' on risk-reward for obesity drug program, shares tumble
Yahoo/AP
Wed, 02/18/09 - 01:36 pm
Arena Pharmaceuticals
obesity
Orexigen to Post Obesity Data in Race With Vivus, Arena
TheStreet.com
Tue, 01/6/09 - 04:51 pm
Orexigen
obesity
Vivus
Arena Pharmaceuticals
Contrave
Qnexa
Biotech Clinical Trials to Watch in 2009
TheStreet.com
Thu, 12/18/08 - 03:43 pm
drug trials
Alnylam
Amgen
Amicus Therapeutics
Arena Pharmaceuticals
Biogen Idec
Chelsea Therapeutics
Genentech
Gilead Sciences
Human Genome Sciences
InterMune
Isis Pharmaceuticals
Neurocrine
ONYX Pharmaceuticals
Orexigen
Osiris Therapeutics
Poniard
Rigel
United Therapeutics
Synta
Arena Seeking a Full BLOOM
Yahoo/Zacks.com
Thu, 12/18/08 - 03:35 pm
Arena Pharmaceuticals
obesity
Arena's partner Ortho-McNeil-Janssen initiates Phase I diabetes trial
Pharmaceutical Business Review
Wed, 12/17/08 - 08:20 am
Arena Pharmaceuticals
Ortho-McNeil
JNJ
diabetes
drug trials
Pages
« first
‹ previous
…
24
25
26
27
28
29
30
31
32